Symbols

NARI(Delisted)

Inari Medical·NASDAQ

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 0

Revenue Beats Expectation

EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About NARI

Inari Medical, Inc.

A medical device company that develops products to treat venous and other diseases

Industry

Established Date

Listing Date

05/22/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

1,300

Fiscal Year Ends

12-31

Website

www.inarimedical.com

Security Type

Common stock

Office address

6001 Oak Canyon, Suite 100, Irvine, California 92618

Business

Introduction

Inari Medical, Inc., was founded in July 2011 in Delaware and is headquartered in Irvine, California. The company is a commercial-stage medical device company that develops products to treat and transform the lives of patients with venous diseases. The company develops, manufactures and sells devices for interventional therapy of venous diseases.

Company Financials

EPS

NARI has released its 2024 Q3 earnings. EPS was reported at -0.2, versus the expected -0.11, missing expectations. The chart below visualizes how NARI has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

NARI has released its 2024 Q3 earnings report, with revenue of 153.39M, reflecting a YoY change of 21.39%, and net profit of -18.37M, showing a YoY change of -680.87%. The Sankey diagram below clearly presents NARI's revenue sources and cost distribution.